Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × INDUSTRY × COVID-19 × Clear all

Phase

Phase 2 7 Phase 1 5 Phase NA 2 Phase 3 2 Phase EARLY_PHASE1 1 Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Multiple Myeloma 17 Solid Tumor 15 Breast Neoplasms 13 Head and Neck Neoplasms 12 Squamous Cell Carcinoma of Head and Neck 11 Sarcoma 11 Stomach Neoplasms 10 Pancreatic Neoplasms 10 Neoplasms 10 Melanoma 9 Lymphoma, B-Cell 9 Colorectal Neoplasms 9 Lymphoma 8 Lung Neoplasms 7 Leukemia, Myeloid, Acute 7 Carcinoma, Non-Small-Cell Lung 7 Burkitt Lymphoma 7 Prostatic Neoplasms 6 Recurrence 5 Ovarian Neoplasms 5 Glioblastoma 5 Carcinoma, Hepatocellular 5 Advanced Solid Tumors 5 Triple Negative Breast Neoplasms 4 Small Cell Lung Carcinoma 4 Osteosarcoma 4 Lymphoma, Non-Hodgkin 4 Leukemia 4 Hematologic Neoplasms 4 Glioma 4

Interventions

NVX-CoV2373 adjuvated lipid nanoparticle 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03305341 2025-06-11

COVSP-BCG

Medicine Invention Design, Inc

Phase EARLY_PHASE1 Active not recruiting

COVID-19

Data powered by HemOnc (CC BY 4.0) Colophon ⚡